Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults

This study has been suspended.

( Based on an interim data review, the DSMB concluded that the vaccine cannot be shown in this trial to prevent HIV infection or affect the course of the disease. )

Study NCT00413725 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: December 18, 2006 Last Updated: May 16, 2008 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study has been suspended.
Estimated Study Completion Date:	October 2011
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)